MyoD is essential in rhabdomyosarcoma by promoting survival through differentiation and CYLD by Alexander R. Oles, Peter Y. Yu, Abasi-ama Udeme, Sudarshana Sharma, Priya Londhe, Benjamin R. Pryce, Erin E. Talbert, Eric M. Hill, Carlos J. Miranda, Brian K. Kaspar, Michael A. Arnold, Jack Hyland, Cheryl A. London, Peter J. Houghton, David J. Wang, Ryan D. Roberts, Denis C. Guttridge

Get full text

The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children’s Oncology Group by Ekene A. Onwuka, Christina L. Magyar, Bailey A. Martin-Giacalone, Michael E. Scheurer, Deborah A. Marquez-Do, Mark Zobeck, Elizabeth G. Atkinson, Erin R. Rudzinski, Michael A. Arnold, Donald A. Barkauskas, David Hall, Javed Khan, Jack F. Shern, Paul Scheet, Brian Crompton, Corinne M. Linardic, Douglas S. Hawkins, Rajkumar Venkatramani, Lisa Mirabello, Chad D. Huff, Melissa A. Richard, Philip J. Lupo

Get full text